India to Kazakhstan: Ledipasvir Export Trade Route

The India to Kazakhstan Ledipasvir corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $28.2K USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's ledipasvir manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $4.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with ledipasvir's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 30.6%, placing it at rank #8 among India's top ledipasvir export destinations globally.

On the import side, key buyers of Indian ledipasvir in Kazakhstan include TO THE ORDER OF, IP DIDI STREET MIKRORAION, IP LILI and 1 others. TO THE ORDER OF is the single largest importer with 1 shipments valued at $20.4K USD.

India's ledipasvir exports to Kazakhstan are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Kazakhstan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HETERO LABS LIMITED, SACRED LEAVES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $4.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ledipasvir 90mg 28 tab batch:hh2308407 manufacturing :08/23exp:07/26 and ledipasvir 90mg 28 tab, batch:hh2308407, manufacturing :08/23,exp:07/26, suggesting that buyers in Kazakhstan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 1 shipments worth $20.4K USD — representing 72% of all ledipasvir imports from India on this route.